Plasma cholinesterase and the morphine receptor (original) (raw)

Stimulation of either cholecystokinin receptor subtype reduces while antagonists potentiate or sensitize a morphine-induced excitatory response

Jorge Florio, Luciano Felicio

Peptides, 2001

View PDFchevron_right

Receptors for morphine and opioids

Emilio Alejandro Hazas sanchez

General Pharmacology: The Vascular System, 1976

View PDFchevron_right

Endogenous morphine and related opiates, a new class of chemical messengers

George B Stefano

Advances in neuroimmunology, 1994

View PDFchevron_right

Cholecystokinin receptor binding in morphine analgesia: Tolerance, withdrawal and abstinence

Fred Nyberg

Neuropeptides, 1994

View PDFchevron_right

Opiate receptors: an introduction

John Carmody

Anaesthesia and intensive care, 1987

View PDFchevron_right

Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity

Frank LaBella

Brain Research, 1979

View PDFchevron_right

Influence of cholinesterase inhibitors, donepezil and rivastigmine on the acquisition, expression, and reinstatement of morphine-induced conditioned place preference in rats

Jerzy Silberring

Behavioural Brain Research, 2014

View PDFchevron_right

A role for heterodimerization of µ and opiate receptors in enhancing morphine analgesia

lakshmi devi

Proceedings of The National Academy of Sciences, 2004

View PDFchevron_right

Endogenous Cholinergic Neurotransmission Contributes to Behavioral Sensitization to Morphine

Mariano Soiza-reilly, Dusica Bajic

PLOS ONE, 2015

View PDFchevron_right

Effects of Cholecystokinin Receptor Agonist and Antagonists on Morphine Dependence in Mice

Mahmoud ghazi-Khansari

Pharmacology & Toxicology, 1995

View PDFchevron_right

Morphine action on cholecystokinin octapeptide release from rat periaqueductal grey slices: Sensitisation by naloxone

Jackie de Belleroche

Neuropeptides, 1987

View PDFchevron_right

Effects of forskolin and phosphodiesterase inhibitors on spinal antinociception by morphine

Jana Sawynok

Pharmacology Biochemistry and Behavior, 1991

View PDFchevron_right

Presynaptic actions of morphine: blockade of cholecystokinin-induced noradrenaline release in the rat supraoptic nucleus

Rosalinda Guevara-Guzmán

The Journal of physiology, 1995

View PDFchevron_right

Chronic opioid antagonist treatment: assessment of receptor upregulation

VICTOR SIERRA

European Journal of Pharmacology, 1989

View PDFchevron_right

Effect of chronic prenatal morphine treatment on μ-opioid receptor-regulated adenylate cyclase activity and neurotransmitter release in rat brain slices

François Hogenboom

European Journal of Pharmacology: Molecular Pharmacology, 1991

View PDFchevron_right

Effects of systemic, intracerebral, or intrathecal administration on an< xh: i> N</xh: i>-methyl-D-aspartate receptor antagonist on associative morphine analgesic …

Gavan McNally

Behavioral neuroscience, 1998

View PDFchevron_right

Antagonism of morphine-induced behavioral suppression by opiate receptor alkylators

rita messing

Pharmacology Biochemistry and Behavior, 1982

View PDFchevron_right

Study on the Activation of the Opioid Receptors by a Set of Morphine Derivatives in a Well-Defined Assay System

Olivier Civelli

Neurochemical Research, 2012

View PDFchevron_right

MOL-13185 1 Morphine-induced µ-opioid receptor desensitization MOL-13185 2 a. Running title Morphine-induced desensitization

Vu Dang

2020

View PDFchevron_right

The effects of recombinant rat μ-opioid receptor activation in CHO cells on phospholipase C, [Ca 2+ ] i and adenylyl cyclase

David Lambert

British Journal of Pharmacology, 1997

View PDFchevron_right

Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists

Jonathan Katz

Life Sciences, 1983

View PDFchevron_right

An Opiate Cocktail that Reduces Morphine Tolerance and Dependence

Jennifer Whistler

Current Biology, 2005

View PDFchevron_right

2013-02-BMC PharmacolTox-opioid receptors-Supp

Robert Levenson

View PDFchevron_right

Involvement of substance P and central opioid receptors in morphine modulation of the CHS response

Donald Lysle

Journal of Neuroimmunology, 2001

View PDFchevron_right

Exploration of drug action on a morphine receptor by methods of enzyme kinetics* 1

Robert Capetola

Journal of Theoretical Biology, 1976

View PDFchevron_right

COMPARISON OF THE RECEPTOR BINDING CHARACTERISTICS OF OPIATE AGONISTS INTERACTING WITH μ- OR K-RECEPTORS

Kenneth Vaux

British Journal of Pharmacology, 1978

View PDFchevron_right

μ opioid receptor signaling in morphine sensitization

Tiziana Rubino

Neuroscience, 2003

View PDFchevron_right

Morphine and its psychiatric implications

George B Stefano

Advances in Neuroimmunology, 1994

View PDFchevron_right

The role of T-type calcium channels in morphine analgesia, development of antinociceptive tolerance and dependence to morphine, and morphine abstinence syndrome

Unal Zagli

Life Sciences, 2002

View PDFchevron_right

Receptores opioides até o contexto atual

Daniel Almeida

Revista Dor, 2012

View PDFchevron_right

Quantitative Studies of the Antagonism by Nalorphine of Some of the Actions of Morphine-Like Analgesic Drugs

Marta Weinstock

British Journal of Pharmacology and Chemotherapy, 1964

View PDFchevron_right

Differential modification of opiate receptor activity by arylsulfatase treatment

Javier Garzón

Biochemical Pharmacology, 1983

View PDFchevron_right

δ-Opioid receptor-mediated increase in cortical extracellular levels of cholecystokinin-like material by subchronic morphine in rats

François Cesselin, H. Collin

Neuropharmacology, 2000

View PDFchevron_right